AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H1328-H1334, 2004; doi:10.1152/ajpheart.01188.2003
0363-6135/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McFalls, E. O.
Right arrow Articles by Ward, H. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McFalls, E. O.
Right arrow Articles by Ward, H. B.

Activation of p38 MAPK and increased glucose transport in chronic hibernating swine myocardium

Edward O. McFalls,1 MingXiao Hou,2 Robert J. Bache,2 Aaron Best,1 David Marx,1 Joseph Sikora,1 and Herbert B. Ward1

1Division of Cardiology, Veterans Affairs Medical Center, and 2Division of Cardiology, University of Minnesota, Minneapolis, Minnesota 55417

Submitted 12 December 2003 ; accepted in final form 23 April 2004


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
In preconditioned myocardium, activation of the mitogen-activated protein kinase (MAPK) p38 leads to increased glucose uptake via enhanced GLUT-4 translocation. Glucose uptake is also increased in chronic hibernating myocardium, but the role of p38 MAPK and GLUT-4 translocation has not been studied. Nine swine underwent instrumentation of the proximal left anterior descending coronary artery (LAD) with a small, external constrictor. At 3 mo after instrumentation, myocardial glucose uptake by PET imaging was higher in the LAD than in the remote region under basal, fasted conditions (0.08 ± 0.02 vs. 0.04 ± 0.01 µmol·min–1·g–1, P < 0.05). Compared with the remote region, the LAD region demonstrated increased membrane-bound GLUT-4 relative to total content (61 ± 04 vs. 45 ± 06%, P < 0.05), higher glycogen (28.37 ± 4.41 vs. 19.26 ± 1.87 mg/g wet wt, P < 0.05), and increased inducible nitric oxide synthase (NOS) activity (1.43 ± 0.34 vs. 0.51 ± 0.21 activity/mg protein, P < 0.05). p38 MAPK was 47 ± 14% higher in the LAD than in the remote region (P < 0.05) and correlated well with the absolute degree of GLUT-4 membrane-bound translocation (r = 0.81, P < 0.01), relative increase in glycogen (r = 0.70, P < 0.05), and total NOS activity (r = 0.68, P < 0.05). In chronic hibernating myocardial tissue, p38 MAPK activation is increased under basal fasted conditions and correlates well with the increased degree of GLUT-4 translocation, glycogen accumulation, and NOS activity. As in preconditioned myocardium, activation of p38 MAPK may play an important role in the metabolic adaptations that characterize chronic hibernating myocardium.

GLUT-4; glucose uptake; preconditioned myocardium; inducible nitric oxide synthase


SINCE THE SEMINAL OBSERVATION of ischemic preconditioning in the anesthetized dog model (16), it is widely accepted that the myocardium can favorably adapt so that necrosis can be attenuated after acute prolonged ischemia. Although this initial period of cardioprotection is brief, it is reacquired 24 h after initiation (1), emphasizing the relevance of preconditioning to patients with chronic myocardial ischemia. The signals that are involved with this early and late period of protection are complex. The mitogen-activated protein kinase (MAPK) p38 belongs to one family of stress-responsive enzymes that may play a critical role in signaling in response to chronic myocardial ischemia. In animal models of myocardial ischemic preconditioning, activation of p38 MAPK is important in reducing infarct size within the "first window of protection" (24) and signals transcriptional events within the "late window of protection," particularly in regard to expression of inducible nitric oxide synthase (iNOS) (3, 35, 36). It also facilitates increased glucose uptake within the preconditioned myocardium by enhancing translocation of the glucose transporter GLUT-4 to the sarcolemma (31).

Whether p38 MAPK activation is also involved in mechanisms that underlie protection in chronically ischemic myocardium is unknown. With the use of dual tracers with PET imaging, hibernating myocardium has been characterized by increased glucose uptake within hypoperfused regions and is predictive of functional reserve after coronary artery revascularization (20, 30). Morphologically, hibernating tissue demonstrates enhanced deposition of glycogen (27, 32) as well as increased iNOS gene expression (9). It is plausible that hibernating and preconditioned myocardium share common signaling pathways, particularly with regard to p38 MAPK. Accordingly, we wished to characterize the activities of regional myocardial p38 MAPK activation in a swine model of chronic regional myocardial ischemia (12) and determine whether the activity of p38 MAPK is related to the degree of GLUT-4 translocation and glycogen storage.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This study was performed under the guidance of the Animal Care Committee at the Veterans Affairs Medical Center and conforms with the National Institutes of Health Guide for the Care and Use of Laboratory Animals [DHHS Publication No. (NIH) 85-23, revised 1996, Office of Science and Health Reports, Bethesda, MD 20892].

Animal Preparation

After an overnight fast, domestic pigs (~10 kg) were sedated with xylazine (2 mg/kg im) and Telazol (tiletamine-zolazepam, 4 mg/kg im), ventilated, and anesthetized with isoflurane (1%). The thorax was prepped and draped, and a left thoracotomy was performed in the fifth intercostal space. The left anterior descending coronary artery (LAD) was dissected free, and a C-shaped occluder (3 mm long, 1.4 mm ID) was secured around the vessel and gently closed with suture. The pericardium and chest were closed in layers. Sterile dressings were applied, and a chest tube was placed and removed within 3 days of surgery. Cephazolin (1 g iv) was given before and 12 h after the procedure and repeated daily for 3 days. Pain prophylaxis was provided during the first 3 postoperative days with buprenorphine (Buprenex, 0.5 mg every 12 h im). Animals were maintained on a diet of standard Purina chow.

Terminal Study and Data Analysis

At 12 wk after instrumentation, fasted animals were brought to the scanner, sedated, and mechanically ventilated. Anesthesia was maintained with a combination of isoflurane (0.8–1.0%) and room air. Before the PET study, two-dimensional echocardiograms were acquired from the right parasternal and apical views to assess regional myocardial function. Regional wall thickening was measured from the anterior (LAD) and posterior (remote) walls and computed as the difference between end-systolic and end-diastolic wall thickness, expressed as a percentage of end-diastolic thickness. End diastole and end systole were defined as the onset of the QRS complex and the frame with the smallest chamber size, respectively. Animals were then positioned on the table so that the heart was in the center of the field of view. An external surface reference was placed on the animals and aligned with a laser to ensure that the position was similar on serial studies. Attenuation of tissue density was determined by a transmission scan using an internal source of radiation. After the transmission scan, [13N]ammonia (15 mCi) was infused intravenously over 20 s, and dynamic scans were obtained over the next 21.5 min. The scanning protocol consisted of one 30-s, twelve 10-s, two 30-s, three 60-s, and one 900-s frame. After 50 min (5 half-lives of [13N]ammonia), [18F]fluoro-2-deoxy-D-glucose (FDG, 6 mCi) was infused, and dynamic scans were acquired over the next 40 min with a scanning protocol of twelve 10-s, six 30-s, four 60-s, three 120-s, three 300-s, and one 600-s frame. An arterial sample was collected for plasma glucose during the FDG scan.

Multiple circular regions of interest (ROIs) were chosen from transverse planes from the blood flow image and saved for analysis. For analysis of the tissue studies, approximately five ROIs were obtained in the LAD and remote territories and for the arterial input function; an ROI was carefully placed in the center of the left ventricle (LV) to minimize the spillover effect from the myocardium to the blood pool. For estimation of regional myocardial blood flow (MBF), we applied a three-compartment model. MBFs were obtained by a nonlinear least-square fitting to the model equation using the input function and tissue samples acquired in the first 6 min of the dynamic scan (17). For estimation of regional myocardial FDG uptake, Patlak plots were generated from the time-activity curves from the LV cavity and each myocardial tissue ROI. Values were then averaged for LAD and remote regions. The model has been previously described and is based on a three-compartment model (21).

Tissue Analysis

After the PET scan, the animals were killed. The heart was sliced into five sections along the longitudinal axis, and the distal ventricular section was placed in freshly prepared triphenyltetrazolium solution for visualization of significant necrosis. The other sections were divided into transmural LAD and remote tissue samples, placed in liquid nitrogen, and stored at –70°C. Sections were also prepared from each region and analyzed by light microscopy by an experienced pathologist. Although triphenyltetrazolium staining showed no evidence of transmural necrosis, significant histological changes were noted in three of the nine pigs, including subendocardial necrosis in one pig and patchy infiltration of fibrosis in two pigs. Separate analysis of the results of the three pigs with the focal histological changes did not differ from the other six pigs; therefore, they were included in the study.

GLUT-4 transport protein. Frozen heart tissue (30–50 mg) was homogenized (4 times for 30 s each) into 1 ml of iced buffer, and a portion of the homogenate was centrifuged at 1,200 g for 30 min. The pellet was incubated in a detergent-based assay buffer (Pierce Biotech, Rockford, IL) and spun at 10,000 g for 5 min. The supernatant was removed and spun at 10,000 g for 5 min. The resulting hydrophobic fraction was used for membrane-bound determinations of GLUT-4 content, and the crude homogenate was used for the total GLUT-4 content. GLUT-4 assays were performed with antiserum (kindly provided by Dr. Howard Haspel), and purity of membrane fractions was confirmed using an anti-Na+-K+-ATPase antibody (Sigma, St. Louis, MO). The immunoblots were quantified from an imaging densitometer (Bio-Rad). For colocalization of GLUT-4 with nuclei by immunohistochemistry, transmural sections from frozen samples were cut on a cryostat microtome, mounted on Superfrost Plus slides, air dried, and stored at –80°C. Slides were fixed in methanol at –20°C, rehydrated with Tris-buffered saline, and blocked with 1% BSA (fraction V) and 0.5% Tween 20. Slides were incubated for 2 h at 37°C with polyclonal rabbit GLUT-4 antiserum and then washed for 1 h in Tris-buffered saline. Fluorescein-labeled donkey anti-rabbit IgG and propidium iodide were used at dilutions of 1:50 and 1:200, respectively. The slides were mounted and examined using confocal microscopy.

Glycogen. Tissue was dissolved in 0.3 N HCl and hydrolyzed using amyloglucosidase. The glucose residues were measured by an NADP-linked spectrophotometric method using glucose-6-phosphate dehydrogenase and hexokinase.

Immunoprecipitations and kinase assays. The immunoprecipitations were carried out in 500-µl aliquots, and immobilized antiphosphorylated p38, ERK, and JNKs were used as the enzyme source. The activity states were determined by using the precipitated protein and in vitro phosphorylations of the substrates. Soluble fractions were subjected to SDS-PAGE, and proteins were transferred onto nitrocellulose membranes. Antiphosphorylated antibodies for activating transcription factor-2 (ATF-2), Elk1, c-Jun, AKT, and AMP-activated protein kinase substrates (Cell Signaling, Beverly, MA) were used as the primary antibodies, and peroxidase-labeled anti-rabbit IgG was used as secondary antibody. Bound antibodies were detected with chemiluminescence using the ECL Plus Western blotting kit (Amersham), and quantification was done with an imaging densitometer. Values were expressed as arbitrary units.

Because ischemia-induced p38 MAPK{beta} activity in preconditioned myocardium is increased to a greater degree than p38 MAPK{alpha} activity (25), we also measured the phosphorylation of ATF-2 substrate after the kinase assays from immunoprecipitates obtained with specific antibodies for p38 MAPK{alpha} (Cell Signaling) and p38 MAPK{beta} (Abgent, San Diego, CA).

NOS activity. Heart tissue was homogenized from LAD and remote regions in three volumes of ice-cold homogenization buffer. The homogenates were centrifuged at 20,000 g for 45 min, and the supernatants were used for measuring NOS activity. The conversion of [L-14C]citrulline from [L-14C]arginine by NOS was measured in the supernatants from tissues. A mixture of supernatant and assay buffer solution was incubated for 20 min at 37°C in the presence or absence of EGTA (1 mmol/l) to determine the contribution of the Ca2+-independent (iNOS) and total NOS activity, respectively. The amount of [L-14C]citrulline was determined with a liquid scintillation counter, and NOS activity was expressed as nanomoles of [L-14C]citrulline formed per gram of protein per minute. Attempts to identify the iNOS protein by Western blots have been unsuccessful; therefore, we have relied on activity measurements of iNOS from the tissue.

Statistics

Values are means ± SE. Differences between LAD and remote regions were tested at P < 0.05 with Student's t-test.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Regional Myocardial Function, Perfusion, and Glucose Uptake

At 3 mo after instrumentation and at the time of the terminal study, a regional wall motion abnormality was observed by two-dimensional echocardiograms in all animals. Systolic wall thickening was 25 ± 3% in the LAD region and 43 ± 4% in the remote region (P < 0.05). PET studies with tracers of blood flow (MBF) and glucose (FDG) were performed at rest during fasted conditions. In the chronically ischemic LAD region, myocardial FDG uptake was increased and blood flow was reduced compared with the corresponding remote territory (Fig. 1). At the time of the PET scan, plasma glucose and lactate were 5.55 ± 0.61 and 1.20 ± 0.10 µmol/l, respectively, and concentration of total free fatty acids was 782 ± 104 µmol/l. Insulin levels were <2.0 µU/ml, confirming fasting conditions.



View larger version (50K):
[in this window]
[in a new window]
 
Fig. 1. At 3 mo after instrumentation and under basal, fasted conditions, imaging with dual tracers of PET demonstrated reduced myocardial blood flow (MBF) and enhanced [18F]fluoro-2-deoxy-D-glucose (FDG) uptake in the chronically ischemic left anterior descending coronary artery (LAD) region. *P < 0.05 vs. remote region.

 
Myocardial Glucose Transporters and Glycogen

The membrane-bound and total content of the GLUT-4 transporter was analyzed by Western blots in the LAD and remote regions. Relative to the total GLUT-4 content, the membrane-bound portion of GLUT-4 in the LAD region was 61 ± 4% and was higher than in the remote region (45 ± 6%, P < 0.05; Fig. 2, A and C). Analysis of the enzyme Na+-K+-ATPase in the membrane and cytosolic fractions showed that the differences in membrane-bound GLUT-4 could not be explained by differences in membrane separation between LAD and remote regions (Fig. 2B). Immunohistochemistry and colocalization of GLUT-4 with nuclei showed more GLUT-4 protein in the sarcolemma of the LAD region, whereas GLUT-4 was observed in cytoplasmic stores in the remote region, with minimal membrane definition (Fig. 2D). Glycogen content was 28.37 ± 4.41 and 19.26 ± 1.87 µmol/g wet wt in LAD and remote regions, respectively (P < 0.05).



View larger version (42K):
[in this window]
[in a new window]
 
Fig. 2. Representative Western blots (A) and grouped data (C) show increased membrane-bound (Mem) GLUT-4 content in LAD myocardial region relative to total GLUT-4 content compared with remote region. B: analysis of Na+-K+-ATPase in membrane and cytosolic (Cyt) fractions showed that differences in membrane-bound GLUT-4 could not be explained by differences in membrane separation between LAD and remote regions. D: immunohistochemistry and colocalization of GLUT-4 (green) with nuclei (red) used to show that GLUT-4 protein was localized to the sarcolemma in the LAD region, whereas it resided in cytoplasmic stores in the remote region, with minimal membrane definition. Magnification x200. *P < 0.05 vs. LAD.

 
MAPK and GLUT-4 Translocation

Total p38 MAPK activation, as determined by the ATF-2 substrate assay, was 47 ± 14% higher in the LAD than in the remote region (P < 0.05). When normalized to the remote region, p38 MAPK{alpha} activity in the LAD region was 1.03 ± 0.04 (not significant), whereas p38 MAPK{beta} activity was 1.30 ± 0.08 (P < 0.05), demonstrating that, similar to preconditioned myocardium, ischemia-induced changes in p38 MAPK in hibernating myocardium involved predominantly the {beta}-isozyme (25). ERK activity, as measured by the Elk1 assay, was also higher in the LAD region by 32 ± 6% (P < 0.05), whereas no differences were noted in the activity of the JNK pathway (c-Jun assay; Fig. 3). When p38 MAPK activity in the LAD region was normalized to that of the remote region, a significant correlation existed between the absolute increase in membrane-bound GLUT-4 (r = 0.81, P < 0.01) and the relative increase in glycogen content within the LAD region (r = 0.70, P < 0.05; Fig. 4). There was no correlation between p38 MAPK activation and relative changes in wall thickening, suggesting that p38 MAPK signaling with global LV dysfunction in congestive heart failure may differ from that with the regional dysfunction that is observed in this model of ischemia (23).



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3. Activity of p38 MAPK was 47 ± 14% higher in the LAD than in the remote region. ERK activity was also higher in the LAD region; no differences were noted in the activity of the JNK pathway. *P < 0.05 vs. remote region.

 


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4. Activity of p38 MAPK in the LAD region was normalized to that of the remote territory and correlated well with the absolute degree of GLUT-4 translocation (A; r = 0.81, P < 0.01) and the relative increase in glycogen (B; r = 0.70, P < 0.05) in the LAD region.

 
Because protein kinase A and B can also increase GLUT-4 translocation, their activities were measured in the LAD region and normalized to the remote territory. Protein kinase A and B were 66 ± 21% and 73 ± 35% higher in the LAD region, respectively (P < 0.05); however, the relative changes in regional activities did not correlate with the absolute degree of GLUT-4 translocation or the relative increase in glycogen in the LAD region.

NOS Activity

In the hibernating LAD region, total NOS and Ca2+-independent iNOS activities were at least twofold higher than in the remote region (Fig. 5). Because the NOS activity from the remote region was higher than expected, two additional pigs (shams) were instrumented with dissection of the LAD artery but not placement of the occluder. Total NOS was 0.31 ± 0.09 and 0.70 ± 0.10 activity/mg protein in the LAD and remote regions, respectively, whereas iNOS in the remote region was 0.07 ± 0.01 activity/mg protein. These values in the remote region were lower than those in the remote region of the hibernating hearts, suggesting that some expression of iNOS may have been a result of signaling to myocardial tissue remote from the ischemic LAD region (29).



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5. A: activity of total nitric oxide synthase (NOS) and Ca2+-independent NOS (iNOS) were increased in the hibernating LAD region compared with the remote territory. B: relative increase in total NOS activity in the LAD region correlated well with the relative increase in p38 MAPK activity (r = 0.68, P < 0.05). *P < 0.05 vs. LAD.

 
A significant correlation existed between the relative degree of p38 MAPK activity and the relative degree of total NOS activity (r = 0.68, P < 0.05). These data suggest that, similar to the second window of preconditioning, p38 MAPK activation may play an important role in the expression of NOS within hibernating myocardium.


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The principal findings of this study are that p38 MAPK activation within chronic hibernating swine myocardium is increased relative to the remote territory and that this increase correlates well with the increase in membrane-bound GLUT-4 glucose transporter, regional glycogen levels, and total NOS activity. This is the first study that has shown that signaling within preconditioned and hibernating myocardium may share common pathways with regard to activation of p38 MAPK.

Myocardial Hibernation In Vivo

With dual tracers of PET imaging, hibernating myocardium has been characterized by increased glucose uptake within hypoperfused regions and is predictive of functional reserve after coronary artery revascularization (20, 30). We previously showed that this swine model of chronic myocardial ischemia is associated with increased glucose uptake relative to MBF by PET and preserved transmural ATP and creatine phosphate (12). In the original description of the model, important adaptations were shown to occur in the coronary arterial resistance vessels in the chronically ischemic LAD region (14). At 3 mo after implantation of the coronary artery constrictor, regional function by segment length crystals and basal blood flow by microspheres were depressed in the absence of significant necrosis or anaerobic glycolysis (6). This finding implies that MBF (and, therefore, energy requirements) can be modestly depressed in chronically ischemic, viable, metabolically active myocardial regions. Thus, in this experimental model, hibernation is characterized by modestly decreased MBF in the presence of some degree of vasodilator reserve and likely follows a transition from repetitive stunning with normal resting blood flow to a state of hibernation with reduced blood flow (2). Although we did not measure vasodilator reserve in the present study, animals were studied 3 mo after instrumentation, which is consistent with the time that hibernation is known to evolve (5).

p38 MAPK and Myocardial Protection

The signals that are involved with the metabolic adaptations that lead to a state of myocardial hibernation are poorly understood (8). The present data suggest that signals that are responsible for early and late preconditioning may also be important in hibernation. The stress-responsive MAPKs consist of a family of highly conserved signaling enzymes that phosphorylate Ser/Thr residues in proteins. p38 MAPK, a subfamily of these enzymes, is activated in response to extracellular stimuli and may play an important role in protein regulation and cell signaling in chronic myocardial ischemia. Activation of p38 can occur in response to free radical generation during low-flow ischemia and hypoxia (10, 11) and may be an important mediator in the infarct-sparing effects of ischemic myocardial preconditioning (34). Thus, when p38 MAPK activation is inhibited before an ischemic preconditioning protocol, the reduction in necrosis during a subsequent sustained period of ischemia and reperfusion is lost (15, 19). Conversely, when p38 MAPK is activated by administration of anisomycin, a preconditioning effect is induced that mimics the protective effects of ischemic preconditioning (18). Activation of p38 MAPK may play a role during the "late" or "second" window of protection (1), possibly by virtue of transcriptional events. For instance, p38 MAPK is activated 24 h after brief regional myocardial ischemia and reperfusion by a mechanism that involves adenosine A1 receptor stimulation (3). Once activated, p38 MAPK, along with the transcriptional factor NF-{kappa}B, can lead to the expression of Ca2+-independent NOS (iNOS) (35). The latter is an important component in the cardioprotection observed in the "late window of ischemic preconditioning" (7).

Myocardial Ischemia and GLUT Transporters

During sustained reductions in coronary blood flow, GLUT-1 and GLUT-4 are mobilized from cytoplasmic stores to the sarcolemma in the absence of insulin (28, 33). Although the precise signaling cascade responsible for this translocation and activation of the GLUT transporters to the sarcolemma is still under investigation, AMP-activated protein kinase and {alpha}-adrenergic receptors have been shown to play an important role in this process (4, 22). The focus of the present study was on GLUT-4 translocation during chronic hibernation, rather than acute ischemia. GLUT-4 is the predominant glucose transporter that has been shown to increase glucose uptake in preconditioning (31) and is the most abundant transporter in fasted pig myocardium (13). Similar to preconditioning, hibernating myocardium demonstrated increased GLUT-4 translocation that was highly correlated with the degree of p38 MAPK activity. Although phosphorylation of protein kinase A and B was also increased in the hibernating myocardial region, there was no correlation between their relative activities and the degree of GLUT-4 translocation.

Methodological Considerations

The hypothesis that a preconditioning effect exists in chronically ischemic, hibernating myocardium has not been tested. Although it might seem reasonable to test whether myocardium within the hibernating regions is protected from necrosis during a prolonged period of severe ischemia, the variable degree of collateral development within the LAD region makes it impossible to impose severe ischemia sufficient to produce infarct. The chronically hibernating myocardial regions share common features with preconditioned myocardium, including increased glucose uptake related to GLUT-4 translocation (31) and enhanced iNOS expression (9). Whether these factors lead to a protection that is comparable to that observed during late preconditioning is speculative and can only be tested after an infusion of agents that inhibit p38 MAPK activation chronically.

"Short-term hibernation," induced by a sustained reduction in regional blood flow in swine, is associated with partial recovery of energy and activation of p38 MAPK by a mechanism that does not involve adenosine receptor stimulation or ATP-dependent K+ channel opening (26). Although this suggests that hibernation and preconditioning do not share common protective mechanisms, this does not eliminate the possibility that a protection in chronic hibernation and the late window of preconditioning share common signaling related to transcriptional events.

In conclusion, in this swine model of chronic hibernation, activation of p38 MAPK is increased and correlates well with the degree of increased GLUT-4 translocation, glycogen accumulation, and NOS activity. The findings suggest that, as with preconditioned myocardium, important metabolic changes within hibernating myocardium are signaled by p38 MAPK.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work was supported in part by a Merit Review Grant from the US Department of Veterans Affairs (to E. O. McFalls), an American Heart Association Affiliate grant (to M. Hou), and a grant from the National Heart, Lung, and Blood Institute (to R. J. Bache).


    FOOTNOTES
 

Address for reprint requests and other correspondence: E. O. McFalls, Cardiology (111C), VA Medical Center, 1 Veterans Dr., Minneapolis, MN 55417 (E-mail: mcfal001{at}tc.umn.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Bolli R. The late phase of preconditioning. Circ Res 87: 972–983, 2000.[Abstract/Free Full Text]
  2. Canty J and Fallavollita J. Chronic hibernation and chronic stunning: a continuum. J Nucl Cardiol 7: 509–527, 2000.[CrossRef][ISI][Medline]
  3. Dana A, Skarli M, Papakrivopoulou J, and Yellon D. Adenosine A1 receptor-induced delayed preconditioning in rabbits: induction of p38 MAP kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism. Circ Res 86: 989–997, 2000.[Abstract/Free Full Text]
  4. Egert S, Nguyen N, and Schwaiger M. Contribution of {alpha}-adrenergic and {beta}-adrenergic stimulation to ischemia-induced glucose transporter (GLUT) 4 and GLUT1 translocation in the isolated perfused rat heart. Circ Res 84: 1407–1415, 1999.[Abstract/Free Full Text]
  5. Fallavollita J, Lim H, and Canty JM Jr. Myocyte apoptosis and reduced SR gene expression precede the transition from chronically stunned to hibernating myocardium. J Mol Cell Cardiol 33: 1937–1944, 2002.
  6. Fallavollita J, Malm B, and Canty JM Jr. Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest. Circ Res 92: 48–55, 2003.[Abstract/Free Full Text]
  7. Guo Y, Jones W, Xuan Y, Tang X, Bao W, Wu W, Han H, Laubach V, Ping P, Yang Z, Qiu Y, and Bolli R. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 96: 11507–11512, 1999.[Abstract/Free Full Text]
  8. Heusch G and Schultz R. Hibernating myocardium. New answers, still more questions! Circ Res 91: 863–865, 2002.[Free Full Text]
  9. Kalra DK, Zhu X, Ramchandani MK, Lawrie G, Reardon MJ, Lee-Jackson D, Winters WL, Sivasubramanian N, Mann DL, and Zoghbi WA. Increased myocardial gene expression of tumor necrosis factor-{alpha} and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans. Circulation 105: 1537–1540, 2002.[Abstract/Free Full Text]
  10. Kulisz A, Chen N, Chandel N, Shao Z, and Schumacker P. Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am J Physiol Lung Cell Mol Physiol 282: L1324–L1329, 2002.[Abstract/Free Full Text]
  11. Luss H, Neumann J, Schmitz W, Schulz R, and Heusch G. The stress-responsive MAP kinase p38 is activated by low-flow ischemia in the in situ porcine heart. J Mol Cell Cardiol 32: 1787–1794, 2000.[CrossRef][ISI][Medline]
  12. McFalls E, Baldwin D, Palmer B, Marx D, Jaimes D, and Ward H. Regional glucose uptake within hypoperfused swine myocardium as measured by PET. Am J Physiol Heart Circ Physiol 272: H343–H349, 1997.[Abstract/Free Full Text]
  13. McFalls E, Murad B, Liouw J, Gannon M, Haspel H, Lange A, Marx D, Sikora J, and Ward H. Glucose uptake and glycogen levels are increased in pig heart after repetitive ischemia. Am J Physiol Heart Circ Physiol 282: H205–H211, 2002.[Abstract/Free Full Text]
  14. Mills I, Fallon J, Wrenn D, Sasken H, Gray W, Bier J, Levine D, Berman S, Gilson M, and Gewirtz H. Adaptive responses of coronary circulation and myocardium to chronic reduction in perfusion pressure and flow. Am J Physiol Heart Circ Physiol 266: H447–H457, 1994.[Abstract/Free Full Text]
  15. Mocanu M, Baxter G, Yue Y, Critz S, and Yellon D. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical. Basic Res Cardiol 95: 472–478, 2000.[CrossRef][ISI][Medline]
  16. Murry C, Jennings R, and Reimer K. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124–1136, 1986.[Abstract/Free Full Text]
  17. Muzik O, Beanlands R, Hutchins G, Mangner T, Nguyen N, and Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 34: 83–91, 1993.[Abstract/Free Full Text]
  18. Nakano A, Baines C, Kim S, Pelech S, Downey J, and Cohen M. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Circ Res 86: 144–151, 2000.[Abstract/Free Full Text]
  19. Nakano A, Cohen M, Critz S, and Downey J. SB203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts. Basic Res Cardiol 95: 466–471, 2000.[CrossRef][ISI][Medline]
  20. Rahimtoola S. The hibernating myocardium. Am Heart J 117: 211–221, 1989.[CrossRef][ISI][Medline]
  21. Ratib O, Phelps M, and Huang S. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 23: 577–586, 1982.[Abstract/Free Full Text]
  22. Russel RR, Bergeron R, Shulman G, and Young L. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol Heart Circ Physiol 277: H643–H649, 1999.[Abstract/Free Full Text]
  23. Schulz R, Aker S, Belosjorow S, Konietzka I, Rauen U, and Heusch G. Stress kinase phosphorylation is increased in pacing-induced heart failure in rabbits. Am J Physiol Heart Circ Physiol 285: H2084–H2090, 2003.[Abstract/Free Full Text]
  24. Schulz R, Belosjorow S, Gres P, Jansen J, Michel M, and Heusch G. p38 MAP kinase is a mediator of ischemic preconditioning in pigs. Cardiovasc Res 55: 690–700, 2002.[Abstract/Free Full Text]
  25. Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I, and Heusch G. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J 17: 1355–1357, 2003.[Abstract/Free Full Text]
  26. Schulz R, Rose J, Post H, and Heusch G. Regional short-term hibernation in swine does not involve endogenous adenosine or KATP channels. Am J Physiol Heart Circ Physiol 268: H2294–H3201, 1995.[Abstract/Free Full Text]
  27. Sherman AJ, Klocke FJ, Decker RS, Decker ML, Kozlowski KA, Harris KR, Hedjbeli S, Yaroshenko Y, Nakamura S, Parker MA, Checchia PA, and Evans DB. Myofibrillar disruption in hypocontractile myocardium showing perfusion-contraction matches and mismatches. Am J Physiol Heart Circ Physiol 278: H1320–H1334, 2000.[Abstract/Free Full Text]
  28. Sun D, Nguyen N, DeGrado T, Schwaiger M, and Brosius F III. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation 89: 793–798, 1994.[Abstract/Free Full Text]
  29. Thomas S, Fallavollita J, Suzuki G, Borgers M, and Canty JM Jr. Dissociation of regional adaptations to ischemia and global myolysis in an accelerated swine model of chronic hibernating myocardium. Circ Res 91: 970–977, 2002.[Abstract/Free Full Text]
  30. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, and Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314: 884–888, 1986.[Abstract]
  31. Tong H, Chen W, London R, Murphy E, and Steenbergen C. Preconditioning-enhanced glucose uptake is mediated by p38 MAPkinase not by phosphatidylinositol 3-kinase. J Biol Chem 275: 11981–11986, 2000.[Abstract/Free Full Text]
  32. Vanoverschelde J, Wijns J, Depre C, Essamri B, Heyndrickx G, Borgers M, Bol A, and Melin J. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 87: 1513–1523, 1993.[Abstract/Free Full Text]
  33. Young L, Rengu Y, Russell R, Hu X, Caplan M, Ren J, Shulman G, and Sinusas A. Low-flow ischemia leads to translocation of canine heart GLUT4 and GLUT1 glucose transporters to the sarcolemma in vivo. Circulation 95: 415–422, 1997.[Abstract/Free Full Text]
  34. Yue Y, Qin Q, Cohen M, Downey J, and Critz S. The relative order of mKATP channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart. Cardiovasc Res 55: 681–689, 2002.[Abstract/Free Full Text]
  35. Zhao T, Taher M, Valerie K, and Kukreja R. p38 triggers late preconditioning elicited by anisomycin in heart: involvement of NF-{kappa}B and iNOS. Circ Res 89: 915–922, 2001.[Abstract/Free Full Text]
  36. Zhao T, Xi L, Chelliah J, Levasseur J, and Kukreja R. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A1 receptors: evidence from gene-knockout mice. Circulation 102: 902–907, 2000.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Exp. Biol.Home page
C. Gaitanaki, M. Mastri, I.-K. S. Aggeli, and I. Beis
Differential roles of p38-MAPK and JNKs in mediating early protection or apoptosis in the hyperthermic perfused amphibian heart
J. Exp. Biol., August 1, 2008; 211(15): 2524 - 2532.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. O. McFalls, R. F. Kelly, Q. Hu, A. Mansoor, J. Lee, M. Kuskowski, J. Sikora, H. B. Ward, and J. Zhang
The energetic state within hibernating myocardium is normal during dobutamine despite inhibition of ATP-dependent potassium channel opening with glibenclamide
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2945 - H2951.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Fulop, Z. Zhang, R. B. Marchase, and J. C. Chatham
Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2227 - H2236.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. Bito, J. van der Velden, P. Claus, C. Dommke, A. Van Lommel, L. Mortelmans, E. Verbeken, B. Bijnens, G. Stienen, and K. R. Sipido
Reduced Force Generating Capacity in Myocytes From Chronically Ischemic, Hibernating Myocardium
Circ. Res., February 2, 2007; 100(2): 229 - 237.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
U. Flogel, T. Laussmann, A. Godecke, N. Abanador, M. Schafers, C. D. Fingas, S. Metzger, B. Levkau, C. Jacoby, and J. Schrader
Lack of Myoglobin Causes a Switch in Cardiac Substrate Selection
Circ. Res., April 29, 2005; 96(8): e68 - e75.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McFalls, E. O.
Right arrow Articles by Ward, H. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McFalls, E. O.
Right arrow Articles by Ward, H. B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.